Akshay Kudpaje
Overview
Explore the profile of Akshay Kudpaje including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kudpaje A, Subash A, Subramaniam N, Palme C, Rao Us V, Arakeri G
Indian J Surg Oncol
. 2022 Apr;
13(1):191-198.
PMID: 35462662
Since the first description of endoscopic thyroid lobectomy in 1997, a variety of techniques have been developed to avoid the visible cervical scar conventionally been associated with thyroidectomy. These "remote...
12.
Rao V, Subash A, Sinha P, Shetty S, Thakur S, Merchant Y, et al.
Indian J Surg Oncol
. 2021 Oct;
12(3):549-553.
PMID: 34658584
The primary objective of this study was to determine, using population-based data, whether the addition of postoperative radiotherapy (RT) provides an overall survival benefit in patients with early primary squamous...
13.
Kudpaje A, Thankappan K, Rajan R, Vidhyadharan S, Balasubramanian D, Wakure A, et al.
Indian J Surg Oncol
. 2021 Oct;
12(3):530-537.
PMID: 34658581
This study was conducted to evaluate the outcomes of re-exploration procedures done after head and neck microvascular flap reconstructions. This is a retrospective review of 109 flaps in 106 patients...
14.
Merchant Y, Kudpaje A, U S Rao V
Oral Oncol
. 2021 Jul;
124:105441.
PMID: 34257023
No abstract available.
15.
Thankappan K, Battoo A, Vidhyadharan S, Kudpaje A, Balasubramanian D, Iyer S
Eur J Surg Oncol
. 2021 Jul;
47(12):2961-2970.
PMID: 34253425
Background: Trans-oral robotic surgery (TORS) and primary radiotherapy are the two modalities used to treat early T stage oropharyngeal squamous cell carcinoma(OPSCC). Prior literature including a recent randomized controlled trial...
16.
U S Rao V, Majumdar K, Subash A, Banerjee N, Sinha P, Prasad R, et al.
Indian J Otolaryngol Head Neck Surg
. 2021 Jun;
73(2):207-211.
PMID: 34150595
In the present study, we look at the prognostic implications of the recovery of vocal cord mobility after treatment in T3 laryngeal and hypopharyngeal cancers with fixed vocal cords. Patients...
17.
Merchant Y, Kudpaje A, U S Rao V
Oral Oncol
. 2021 Feb;
119:105219.
PMID: 33593631
No abstract available.
18.
U S Rao V, Subash A, R Bhargavi V, Sinha P, Bagadia R, Kudpaje A, et al.
Head Neck
. 2020 Dec;
43(4):1174-1183.
PMID: 33368808
Background: The incidence of oropharyngeal carcinoma has been on the rise in recent decades. About 30% of patients who undergo definitive chemoradiation as the initial treatment present with residual/recurrent disease....
19.
George A, Shetty S, Subash A, Kudpaje A, U S Rao V
Oral Surg Oral Med Oral Pathol Oral Radiol
. 2020 Nov;
131(1):139-140.
PMID: 33187939
No abstract available.
20.
Merchant Y, Subash A, Shetty S, George A, Kudpaje A, U S Rao V
Oral Oncol
. 2020 Aug;
111:104980.
PMID: 32861563
No abstract available.